Teva Pharmaceutical Industries Ltd SEC filings TEVA
Teva Pharmaceutical Industries Ltd has 1,001 filings in SEC EDGAR's recent list, going back to Oct 17, 2017. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Sep 11, 2026 | — |
| FWP | Free writing prospectus | Sep 10, 2026 | — |
| FWP | Free writing prospectus | Sep 10, 2026 | — |
| 424B5 | Prospectus supplement | Sep 8, 2026 | — |
| F-6 POS | Filing | Jul 29, 2026 | — |
| 424B5 | Prospectus supplement | May 22, 2025 | — |
| FWP | Free writing prospectus | May 20, 2025 | — |
| 424B5 | Prospectus supplement | May 19, 2025 | — |
| S-3ASR | Automatic shelf registration | Feb 7, 2025 | — |
| 424B5 | Prospectus supplement | Mar 3, 2023 | — |
| FWP | Free writing prospectus | Mar 1, 2023 | — |
| 424B5 | Prospectus supplement | Feb 27, 2023 | — |
| F-6EF | Filing | Feb 8, 2023 | — |
| 424B5 | Prospectus supplement | Nov 4, 2021 | — |
| FWP | Free writing prospectus | Nov 2, 2021 | — |
| 424B3 | Prospectus | Oct 27, 2021 | — |
| S-3ASR | Automatic shelf registration | Oct 27, 2021 | — |
| 424B3 | Prospectus | Aug 17, 2020 | — |
| S-4 | Registration for a merger or exchange | Aug 5, 2020 | — |
| S-8 POS | Filing | Aug 5, 2020 | — |
| S-8 POS | Filing | Aug 5, 2020 | — |
| S-8 POS | Filing | Aug 5, 2020 | — |
| S-8 POS | Filing | Aug 5, 2020 | — |
| S-8 POS | Filing | Aug 5, 2020 | — |
| S-8 | Employee stock plan registration | Aug 5, 2020 | — |
| F-6 | Filing | Nov 13, 2018 | — |
| 424B3 | Prospectus | Apr 19, 2018 | — |
| S-4 | Registration for a merger or exchange | Apr 2, 2018 | — |
| S-3/A | Form s-3 amendment no. 2 | Mar 28, 2018 | — |
| S-3/A | Filing | Feb 16, 2018 | — |
| S-3 | Shelf registration | Jan 29, 2018 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TEVA (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Tel Aviv
- SEC filer status
- Large accelerated filer
- SEC CIK
- 818686
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED (until Jan 16, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.